Form D · Other Health Care
Long View Labs Inc
San Francisco, CA · CIK 0001869203
Offering snapshot reported Jun 23, 2021 · SEC filing
- Reported sold
- $500K Indefinite offering
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 23, 2021 | Initial | $500,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-403991
Source: Form D, filed Jun 23, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Aidan Dewar | Director |
| Stephanie Liu | Director |
| David Sam Perkins | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2512 Octavia Street
San Francisco, CA, 94123
San Francisco, CA, 94123